M. Pepels

Addition of zoledronic acid to neoadjuvant chemotherapy does not enhance tumor response in patients with HER2-negative stage II/III breast cancer: the NEOZOTAC trial (BOOG 2010-01).

H. Putter, J. Nortier, J. Kroep, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Blended online learning for oncologists to improve skills in shared decision making about palliative chemotherapy: a pre-posttest evaluation

E. Smets, M. Hendriks, I. Henselmans, 2023, Supportive Care in Cancer.

Life-threatening interstitial lung disease associated with trastuzumab: case report

K. Boomars, P. Hupperets, R. Kimmenade, 2009, Breast Cancer Research and Treatment.